Feasibility, acceptability of enteral tube feeding and self-insertion of a nasogastric tube in the nutritional management of digestive cancers, impact on quality of life

No study has evaluated the feasibility of enteral tube feeding (ETF) in undernourished patients with newly diagnosed gastrointestinal (GI) cancer.Evaluate the acceptability of ETF in patients unable to increase their dietary intake and with a weight loss10% or albuminemia30 g/L or BMI18.5 before surgery, or a weight loss5% during chemotherapy. The feasibility of self-insertion of a nasogastric tube was also assessed.A total of 308 patients were nutritionally screened during a one-year period. ETF was indicated in 123 cases. Overall acceptability was 78.9% and was higher when weight loss was10% (p 0.0001) and before surgery (p 0.0001), lower during chemotherapy (p 0.0001), while not influenced by dietary intake or location of the cancer. Forty patients managed a daily self-insertion of the feeding tube (45.5%) and 48 had a nasogastric tube maintained in place. All Quality of Life (QoL) parameters were significantly improved, notably physical role functioning (+20.9% ± 24.0, p 0.005) and mental health (+21.0% ± 17.7 p 0.005).According to the present algorithm, ETF was indicated in 39.9% of cases and accepted in 78.9% of newly diagnosed patients with primary GI cancer while improving QoL. This study strengthens the place of self-insertion of feeding tubes in clinical practise.